Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 50

1.

Neurotensin and growth of normal and neoplastic tissues.

Evers BM.

Peptides. 2006 Oct;27(10):2424-33. Epub 2006 Aug 9. Review.

PMID:
16904238
2.

Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.

Kitabgi P.

Curr Opin Drug Discov Devel. 2002 Sep;5(5):764-76. Review.

PMID:
12630297
3.

[Neurotensin--structure, origin and biological function].

Kulińska-Niedziela I, Paluszak J.

Postepy Hig Med Dosw. 1997;51(3):329-42. Review. Polish.

PMID:
9333784
4.

The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.

Kasckow J, Nemeroff CB.

Regul Pept. 1991 Oct 29;36(2):153-64. Review.

PMID:
1666685
5.

Endocrine gene neurotensin: molecular mechanisms and a model of intestinal differentiation.

Evers BM.

World J Surg. 2002 Jul;26(7):799-805. Epub 2002 Apr 18. Review.

PMID:
11960215
6.

Involvement of neurotensin in cancer growth: evidence, mechanisms and development of diagnostic tools.

Carraway RE, Plona AM.

Peptides. 2006 Oct;27(10):2445-60. Epub 2006 Aug 2. Review.

PMID:
16887236
7.

Neurotensin and dopamine interactions.

Binder EB, Kinkead B, Owens MJ, Nemeroff CB.

Pharmacol Rev. 2001 Dec;53(4):453-86. Review.

8.

Multitasking with neurotensin in the central nervous system.

Dobner PR.

Cell Mol Life Sci. 2005 Sep;62(17):1946-63. Review.

PMID:
16003489
9.
10.

Gastrointestinal growth factors and neoplasia.

Evers BM.

Am J Surg. 2005 Aug;190(2):279-84. Review.

PMID:
16023446
11.

The regulatory role of neurotensin on the hypothalamic-anterior pituitary axons: emphasis on the control of thyroid-related functions.

Stolakis V, Kalafatakis K, Botis J, Zarros A, Liapi C.

Neuropeptides. 2010 Feb;44(1):1-7. doi: 10.1016/j.npep.2009.09.005. Epub 2009 Oct 29. Review.

PMID:
19878995
12.

[Neurotensin: reception and intracellular mechanisms of signaling].

Osadchiĭ OE.

Usp Fiziol Nauk. 2006 Apr-Jun;37(2):52-70. Review. Russian.

PMID:
16758885
13.

Novel signals mediating the functions of somatostatin: the emerging role of NO/cGMP.

Thermos K.

Mol Cell Endocrinol. 2008 May 14;286(1-2):49-57. doi: 10.1016/j.mce.2008.02.008. Epub 2008 Feb 17. Review.

PMID:
18384933
14.

Novel treatments of schizophrenia: targeting the neurotensin system.

Kinkead B, Nemeroff CB.

CNS Neurol Disord Drug Targets. 2006 Apr;5(2):205-18. Review.

PMID:
16611093
15.

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.

Roberts PJ, Der CJ.

Oncogene. 2007 May 14;26(22):3291-310. Review.

PMID:
17496923
16.

Neurotensin receptors as modulators of glutamatergic transmission.

Ferraro L, Tomasini MC, Mazza R, Fuxe K, Fournier J, Tanganelli S, Antonelli T.

Brain Res Rev. 2008 Aug;58(2):365-73. Epub 2007 Nov 26. Review.

PMID:
18096238
17.

Interactions between neurotensin receptors and G proteins.

Pelaprat D.

Peptides. 2006 Oct;27(10):2476-87. Epub 2006 Aug 17. Review.

18.

Neurotensin agonists as an alternative to antipsychotics.

Boules M, Fredrickson P, Richelson E.

Expert Opin Investig Drugs. 2005 Apr;14(4):359-69. Review.

PMID:
15882113
19.

Bioactive analogs of neurotensin: focus on CNS effects.

Boules M, Fredrickson P, Richelson E.

Peptides. 2006 Oct;27(10):2523-33. Epub 2006 Aug 1. Review.

PMID:
16882457
20.

Antineoplastic effect of proliferation signal inhibitors: from biology to clinical application.

Bertoni E, Salvadori M.

J Nephrol. 2009 Jul-Aug;22(4):457-62. Review.

PMID:
19662600

Supplemental Content

Support Center